Global Biospecimen Leader to Unveil Transformative Tool for Oncology Studies HUNTSVILLE, Ala., Feb. 25, 2025 /PRNewswire/ -- Discovery Life Sciences…
Companies Advance Collaborative Clinical Development of iTOL-102: A Potential Cure for Diabetes Without the Need for Chronic Life-long Immune Suppression…
VANCOUVER, BC, Feb. 25, 2025 /PRNewswire/ -- AI users in healthcare see significant opportunities in using unstructured data for innovation…
Addition of New Team Members will Bolster Venture Builder's Expertise in Microbiome R&D and Data Science TOKYO, Feb. 25, 2025 /PRNewswire/…
The major rollout brings new opportunities for engagement, fostering connection and combating isolation to seniors all across the Southern United…
FDA feedback confirms Adial’s proposed in vitro bridging strategy to the Phase 3 formulation to fulfill the bridging requirement for…
Silexion Completes Data Collection Phase in First-Ever Evaluation of SIL-204 in Clinically Relevant Orthotopic Models; Analysis Underway with Initial Results…
Preeminent retinal disease expert panel to support Alkeus’ development programs and scienceCAMBRIDGE, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Alkeus…
SARASOTA, Fla., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company advancing innovative treatments for…
Several subjects who received the highest dose in Phase 1 will also be included in Phase 2OCALA, Fla., Feb. 25,…